Monogenic human obesity: Role of the leptin-melanocortin system in the regulation of food intake and body weight in humans;Obesidad monogénica humana: Papel del sistema leptina-melanocortina en la regulación de la ingesta de alimentos y el peso corporal en humanos

Anales del Sistema Sanitario de Navarra

Volumn 35, Issue 2, 2012, Pages 285-293

  Gonzalez Jimenez E ^a   Aguilar Cordero, M J ^a   Padilla Lopez C A ^b   Garcia Garcia I ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b Grupo de Investigacion CTS 367   (Spain)

Author keywords

Leptin; MC4R; Melanocortins; Obesity; Proopiome lanocortin

Indexed keywords

FURIN; LEPTIN; MELANOCORTIN; PROOPIOMELANOCORTIN;

BODY WEIGHT; CALORIC INTAKE; FOOD INTAKE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LIPID STORAGE; MONOGENIC DISORDER; OBESITY; REVIEW;

EID: 84866141714     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: 10.4321/s1137-66272012000200010     Document Type: Review

References (53)

1. Aguilar Cordero MJ, González Jiménez E, García García CJ, García López PA, Álvarez Ferre J, Pa-Dilla López CA et al. Obesity in a school chil-dren population from Granada: assessment of the efficacy of an educational interven-tion. Nutr Hosp 2011; 26: 636-641.
2. Aguilar Cordero MJ, González Jiménez E, Sánchez Perona J, Padilla López CA, Álvarez Ferre J, Mur Villar N et al. The Guadix study of the effects of a Mediterranean-diet breakfast on the pos-tprandial lipid parameters of overweight and obese pre-adolescents. Nutr Hosp 2010; 25: 1025-1033.
3. Ochoa MC, Martí A, Martínez JA. Estudios so-bre la obesidad en genes candidatos. Med Clin (Barc) 2004; 122: 542-551.
4. Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B. The human obesity gene map: the 2005 update. Obesity 2006; 14: 529-644.
5. Macneil DJ, Howard AD, Guan X, Fong TM, Nar-Gund RP, Bednarek MA et al. Eur J Pharmacol 2002; 450: 93-109.
6. Rosadoc EL, Monteiro JB, Chaia V, Do Lago MF. Efecto de la leptina en el tratamiento de la obesidad e influencia de la dieta en la se-creción y acción de la hormona. Nutr Hosp 2006; 21: 686-693.
7. Bulló Bonet M. La leptina en la regulación del balance energético. Nutr Hosp 2002; 17 (Supl. 1): 42-48.
8. Robertson SA, Leinninger GM, Myers MG. Mole-cular and neural mediators of leptin action. Physiol Behav 2008; 94: 637-642.
9. Cone RD. Anatomy and regulation of the cen-tral melanocortin system. Nat Neurosci 2005; 8: 571-578.
10. Seeley RJ, Drazen DL, Clegg DJ. The critical role of the melanocortin system in the con-trol of energy intake. Annu Rev Nutr 2004; 24: 133-149.
11. Ivanova E, Kelsey G. Imprinted genes and hypothalamic function. J Mol Endocrinol 2011; 47: 67-74.
12. Hung CC, Luan J, Sims M, Keogh JM, Hall C, Wareham NJ et al. Studies of the SIM1 gene in relation to human obesity and obesity-re-lated traits. Int J Obes (Lond) 2007; 31: 429-434.
13. Holder Jr JL, Butte NF, Zinn AR. Profound obesity associated with a balanced translo-cation that disrupts the SIM1 gene. Hum Mol Genet 2000; 9: 101-108.
14. Ghoussaini M, Stutzmann F, Couturier C, Vatin V, Durand E, Lecoeur C et al. Analysis of the SIM1 contribution to polygenic obesity in the French population. Obesity 2010; 18: 1670-1675.
15. Tolson KP, Gemelli T, Gautron L, Elmquist JK, Zinn AR, Kublaoui BM. Postnatal Sim1 defi-ciency causes hyperphagic obesity and re-duced Mc4r and oxytocin expression. Neuro-biol Dis 2010; 30: 3803-3812.
16. Tapia-Arancibia L, Rage F, Givalois L, Arancibia S. Physiology of BDNF: focus on hypothalamic function. Front Neuroendocrinol 2004; 25: 77-107.
17. Gray J, Yeo GS, Cox JJ, Morton J, Adlam ALR, Keogh JM. Hyperphagia, severe obesity, im-paired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 2006; 55: 3366-3371.
18. Han JC, Liu QR, Jones M. Brain-derived neuro-trophic factor and obesity in the WAGR syn-drome. N Engl J Med 2008; 359: 918-927.
19. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the Mouse obese gene and its human homo-logue. Nature 1994; 372: 425-432.
20. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D. Weight reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
21. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903-908.
22. González Jiménez E, Aguilar Cordero MJ, Gar-Cía García CJ, García López PA, Álvarez Ferre J, Padilla López CA. Leptin: a peptide with the-rapeutic potential in the obese. Endocrinol Nutr 2010; 57: 322-327.
23. Oswal A, Yeo GS. The leptin melanocortin pathway and the control of body weight: les-sons from human and murine genetics. Obes Rev 2007; 8: 293-306.
24. Andiran N, Celik N, Andiran F. Homozygosity for two missense mutations in the leptin re-ceptor gene (P316:W646C) in a Turkmenian girl with severe early-onset obesity. J Pediatr Endocrinol Metab 2011; 24: 1043-1045.
25. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998; 391: 900-904.
26. Ren D, Li M, Duan C, Rui L. Identification of SH2-B as a key regulator of leptin sensitivi-ty, energy balance, and body weight in mice. Cell Metab 2005; 2: 95-104.
27. Gantz I, Fong TM. The melanocortin system. Am J Physiol Endocrinol Metab 2003; 284: 468-474.
28. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmo-Re JH, Fang Q, Berkemeier LR. Targeted disrup-tion of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-141.
29. Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in human MC4R is asso-ciated with a dominant form of obesity. Nat Genet 1998; 20: 113-114.
30. Martí A, Corbalán MS, Forga L, Martínez JA, Hinney A, Hebebrand J. A novel nonsense mu-tation in the melanocortin-4 receptor asso-ciated with obesity in a Spanish population. Int J Obes 2003; 27: 385-388.
31. Brumm H, Mühlhaus J, Bolze F, Scherag S, Hinney A, Hebebrand J et al. Rescue of Melanocortin 4 Receptor (MC4R) Nonsense Mutations by Aminoglycoside-Mediated Read-Through. Obesity (Silver Spring) 2012; 20: 1074-1081.
32. Tao YX. Mutations in the melanocortin-3 re-ceptor (MC3R) gene: Impact on human obe-sity or adiposity. Curr Opin Investig Drugs 2010; 11: 1092-1096.
33. Bochukova EG, Huang N, Keogh J, Henning E, Pur-Mann C, Blaszczyk K et al. Large, rare chromo-somal deletions associated with severe early-onset obesity. Nature 2010; 463: 666-670.
34. Millington GWM. The role of proopiomela-nocortin (POMC) neurones in feeding beha-viour. Nutr Metab 2007; 4: 18.
35. Choquet H, Stijnen P, Creemers JW. Genetic and functional characterization of PCSK1. Methods Mol Biol 2011;768: 247-253.
36. Cowley MA, Smart JL, Rubinstein M, Cerdán MG, Diano S, Horvath TL. Leptin activates anorexi-genic POMC neurons through a neural net-work in the arcuate nucleus. Nature 2001; 411: 480-484.
37. Lautenbach A, Breitmeier D, Kuhlmann S, Nave H. Human obesity reduces the number of hepatic leptin receptor (ob-R) expressing NK cells. Endocr Res 2011; 36:158-166.
38. Wauman J, Tavernier J. Leptin receptor sig-naling: pathways to leptin resistance. Front Biosci 2011; 1: 2771-2793.
39. Myers MG. Keeping the fat off with nesfatin. Nat Med 2006; 12: 1248-1249.
40. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR. Brain-derived neurotrophic factor regulates energy balance downstream of me-lanocortin-4 receptor. Nat Neurosci 2003; 6: 736-742.
41. Hu Y, Russek SJ. BDNF and the diseased ner-vous system: a delicate balance between adaptive and pathological processes of gene regulation. J Neurochem 2008; 105: 1-17.
42. Han JC, Liu QR, Jones M, Levinn RL, Menzie CM, Jefferson-George KS, et al. Brain derived neu-rotrophic factor and obesity in the WAGR syndrome. N Engl J Med 2008; 359: 918-927.
43. Yeo GS, Connie Hung CC, Rochford J, Keogh J, Gray J, Sivaramakrishnan S. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neu-rosci 2004; 7: 1187-1189.
44. Gray J, Yeo GS, Cox JJ, Morton J, Adlam ALR, Keogh JM et al. Hyperphagia, severe obesi-ty, impaired cognitive function, and hype-ractivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 2006; 55: 3366-3371.
45. Noble EE, Billington C, Kotz CM, Wang C. The lighter side of BDNF. Am J Physiol 2011; 300: 1053-1069.
46. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM. Effects of recombi-nant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341: 879-884.
47. Donato J Jr, Cravo RM, Frazão R, Elias CF. Hypothalamic sites of leptin action linking metabolism and reproduction. Neuroendo-crinology 2011; 93: 9-18.
48. Dhillon SS, Mcfadden SA, Chalmers JA, Cen-Teno ML, Kim GL, Belsham DD. Cellular lep-tin resistance impairs the leptin-mediated suppression of neuropeptide y secretion in hypothalamic neurons. Endocrinology 2011; 152: 4138-4147.
49. Schuster B, Kovaleva M, Sun Y, Regenhard P, Matthews V, Grötzinger J et al. Signaling of hu-man ciliary neurotrophic factor (CNTF) revi-sited. The interleukin-6 receptor can serve as an alpha-receptor for CTNF. J Biol Chem 2003; 278: 9528-9535.
50. Reinehr T, Hebebrand J, Friedel S, Toschke AM, Brumm H, Biebermann et al. Lifestyle interven-tion in obese children with variations in the melanocortin 4 receptor gene. Obesity 2009; 17: 382-389.
51. Beckers S, Zegers D, Van Gaal LF, Van Hul W. The role of the leptin-melanocortin signa-lling pathway in the control of food intake. Crit Rev Eukaryot Gene Expr 2009; 19: 267-287.
52. González Jiménez E. Genes and obesity: a cau-se and effect relationship. Endocrinol Nutr 2011; 58: 492-496.
53. Zurbano Inchusta R, Ochoa Nieto MC, Moreno-Aliaga MJ, Marti Del Moral A. Estudios sobre obesidad de origen monogénico en huma-nos. Rev Esp Obes 2004; 2: 269-278.